Effect of 1-aminoadamantanes on the MAO activity in brain, liver, and kidney of the rat.

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Arzneimittel-Forschung

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 6891223
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro studies on the possible effects of 1-aminoadamantanes on the serotonergic system in M. Parkinson

  2005cited by this paper
• The effect of amantadine on motor activity and catalepsy in rats

  2004cited by this paper
• [The action of 1-aminoadamantane. Comparative studies with isolated nerve endings and thrombocytes on the release of serotonin and dopamine].

  1977cited by this paper
• Phase separation in phosphatidylcholine bilayers as a predictor of inhibition of blood platelet aggregation by amantadines.

  1977cited by this paper
• [Effects of intravenous administration of memantine in parkinsonian patients (author's transl)].

  1977cited by this paper
• Monoamine oxidase activities in neuronal and glial fractions from regional areas of rat brain

  1976cited by this paper
• Substrate specificity of the different forms of monoamine oxidase in rat liver mitochondria.

  1976cited by this paper
• Monoamine oxidase activities towards biogenic monoamines in several regions of rat brain

  1975cited by this paper
• Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative.

  1974cited by this paper
• Dopamine release and direct dopamine receptor activation in the central nervous system by D-145, an amantadine derivative.

  1973cited by this paper
• Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: a possible mode of action in Parkinson's disease.

  1971cited by this paper
• On the mode of action of amantadine

  1970cited by this paper
• Amantadine in the treatment of Parkinson's disease.

  1969cited by this paper
• MICRODETERMINATION OF MONOAMINE OXIDASE AND 5‐HYDROXYTRYPTOPHAN DECARBOXYLASE ACTIVITIES IN NERVOUS TISSUES

  1965cited by this paper
• The determination of enzyme inhibitor constants.

  1953cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Amantadine: reappraisal of the timeless diamond—target updates and novel therapeutic potentials

  2021cites this paper
• Amantadine in the treatment of Parkinson's disease and other movement disorders.

  2021cites this paper
• Skeletal muscle

  2020cites this paper
• Acute and chronic effects of single dose memantine after controlled cortical impact injury in adult rats

  2019cites this paper
• An Analysis of the Behavioral and Neurochemical Effects of Himantane on the Dynamics of the Ethanol-Induced Hyperlocomotor Response in DBA/2 Mice

  2018cites this paper
• harmacological characterizations of memantine-induced disruption of prepulse nhibition of the acoustic startle response in mice : Involvement of dopamine D 2 nd 5-HT 2 A receptors

  2010cites this paper
• Influence of memantine on brain monoaminergic neurotransmission parameters in mice: neurochemical and behavioral study.

  2009cites this paper
• CHAPTER 35 – Skeletal Muscle

  2009cites this paper
• Memantine does not show intracellular block of the NMDA receptor channel.

  2008cites this paper
• Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse.

  2007cites this paper
• Oxidative Stress in Anticholinesterase-Induced Excitotoxicity

  2006cites this paper
• Memantine does not influence AChE inhibition in rat brain by donepezil or rivastigmine but does with DFP and metrifonate in in vivo studies

  2005cites this paper
• Synthesis of 61-bis(1-adamantylcarbamoyl)-1,2-methano[60]fullerene and its antagonistic effect on haloperidol-induced catalepsy in mice.

  2004cites this paper
• Profile of Ketamine, CPP, Dextromethorphan, and Memantine

  2003cites this paper
• Role of high-energy phosphates and their metabolites in protection of carbofuran-induced biochemical changes in diaphragm muscle by memantine

  2000cites this paper
• Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data.

  1999cites this paper
• Possible Use of Amantadine in Depression

  1999cites this paper
• Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies.

  1997cites this paper
• Twenty-five years of amantadine therapy in Parkinson's disease.

  1995cites this paper
• Protection and reversal by memantine and atropine of carbofuran‐induced changes in biomarkers

  1993cites this paper
• Prophylactic and therapeutic efficacy of memantine against seizures produced by soman in the rat.

  1992cites this paper
• Studies on the mechanism of action of the antiparkinsonian drugs memantine and amantadine: no evidence for direct dopaminomimetic or antimuscarinic properties.

  1992cites this paper
• Novel effects of memantine in antagonizing acute aldicarb toxicity: Mechanistic and applied considerations

  1991cites this paper
• Effects of L-deprenyl and amantadine in an MPTP-model of parkinsonism.

  1990cites this paper
• Methyl parathion acute toxicity: prophylaxis and therapy with memantine and atropine.

  1990cites this paper
• Prevention and antagonism of acute carbofuran intoxication by memantine and atropine.

  1989cites this paper
• Effects of memantine on the frog neuromuscular junction.

  1986cites this paper
• Effects of DU 24565 (6-nitroquipazine) on serotoninergic and noradrenergic neurones of the rat brain and comparison with the effects of quipazine

  1984cites this paper
• [Pharmacodynamics and pharmacokinetics of memantine].

  1983cites this paper
• [The Effect of memantine on spinal alpha-motoneurons and on the content of dopamine, noradrenaline and serotonin in the striatum and lumbar spinal cord].

  1982cites this paper
• Distribution of memantine in brain, liver, and blood of the rat.

  1982cites this paper